Detalhe da pesquisa
1.
Label-free quantitative proteomics reveals aberrant expression levels of LRG, C9, FN, A1AT and AGP1 in the plasma of patients with colorectal cancer.
Clin Proteomics
; 20(1): 15, 2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024778
2.
Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study.
Molecules
; 27(18)2022 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36144640
3.
Glycoproteomic Analysis Reveals Aberrant Expression of Complement C9 and Fibronectin in the Plasma of Patients with Colorectal Cancer.
Proteomes
; 8(3)2020 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971853
4.
Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
Int J Oncol
; 51(1): 269-280, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28560424